tbuckley/cabot-search huggingface dataset:
Disorders of Communion
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Response
Authors: E. RIBOLI, P. TONIOLO
Journal: JNCI Journal of the National Cancer Institute (1989)

Journal Article Response Get access ELIO RIBOLI, ELIO RIBOLI International Agency for Research on Cancer150, Cours Albert Thomas 69372 Lyon, Cedex 08 France Search for other works by this author on: Oxford Academic PubMed Google Scholar PAOLO TONIOLO PAOLO TONIOLO * Department of Environmental Medicine New York University Medical Center341 East 25th Street New York NY 10010 *Correpondence to: Paolo Toniolo, M.D., Department of Environmental Medicine, New York University Medical Center, 341 East 25th St, New York, NY 10010 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 81, Issue 18, 20 September 1989, Pages 1423–1424, https://doi.org/10.1093/jnci/81.18.1423 Published: 20 September 1989
PTU-313 Looking for satisfaction in nhs – patients, gps and specialist doctors
Authors: MF Jaboli, T Rayne, C Durcan, O Epstein
Journal: Gut (2015)

<h3>Introduction</h3> In NHS it is time for innovation. Instead of patients suffering the long waiting times and a multitude of journeys to and from hospital, they should receive a diagnosis with immediate treatment within a month of referral. Hospitals are under pressure to achieve targets and need to improve their communication with patients and GEneral Practitioner (GP). A new type of Outpatient clinic, the Split Clinic (SC), in Gastroenterology has been piloted and feedback from the patients and GP obtained. <h3>Method</h3> Questionnaires about the quality of the consultation they received in the SC, were issued to 118 patients. The referrals were previewed and investigations pre-booked after contacting the patients. Patients return home with a “Easy View Care Map” (EVCM) document which summarises the consultation in a Mind Map format. The questionnaire asked four simple questions with five options (from strongly agreed to strongly disagree). A second survey was undertaken to assess the acceptability to GPs of the EVCM. 266 questionnaires were sent out to all the GPs containing seven questions and same five reply options. <h3>Results</h3> The responses of the 118 patients are summarised in Table 1. 110 of 266 (41%) of the GP questionnaires were returned. The responses are summarised in Table 2. <h3>Conclusion</h3> We think that the SC is an innovative clinic because the patients liked the fact that it was well organised, efficient and saved them time. GPs approved the new EVCM document. We, as providers of the NHS, found great satisfaction delivering diagnosis and treatment in one morning instead of 3 months. Overall quality of life is improved together with cost savings. <h3>Disclosure of interest</h3> None Declared.
Research resolves uncertainties of regulation
Authors: K. Glasbrenner
Journal: JAMA (1985)

Located in the woodlands of what was once part of the Pine Bluff Arsenal's biological warfare facility in Jefferson, Ark, is the National Center for Toxicological Research (NCTR)—the research arm of the FDA. Director Ronald Hart, PhD, says the center, which lies approximately 1,600 km (1,000 miles) southwest of the agency's headquarters, "was created to serve as a research base, not just for the FDA, but for other regulatory agencies as well." He goes on to explain that the investigations sponsored by the NCTR combine basic research with the testing, surveillance, and monitoring conducted by the Environmental Protection Agency (EPA), National Institute of Environmental Health Sciences, and the Centers for Disease Control. Hart emphasizes that the NCTR is not a testing laboratory. "We resolve the uncertainties of regulation," he explains, which involves identifying problems and using basic research. In general, he adds, "all center research programs are directed toward the
Surgical Care Improvement Project Adherence and Postoperative Infections
Authors: Jay A. Gold
Journal: JAMA (2010)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Statistical Studies in Genetic Toxicology: A Perspective from the U.S. National Toxicology Program
Authors: Barry H. Margolin
Journal: Environmental Health Perspectives (1985)

This paper surveys recent, as yet unpublished, statistical studies arising from research in genetic toxicology within the U.S. National Toxicology Program (NTP). These studies all involve analyses of data from Ames Salmonella/microsome mutagenicity tests, but the statistical methodologies are broadly applicable. Three issues are addressed: First, what is a tenable sampling model for Ames test data, and how does one best test the adequacy of the Poisson sampling assumption? Second, given that nonmonotone dose-response curves are fairly common in the Salmonella assay, what new statistical techniques or modifications of existing ones seem appropriate to accommodate to this reality? Finally, an intriguing question: How can the extensive NTP Ames test data base be used to assess the characteristics of any mutagen-nonmutagen decision rule? The last issue is illustrated with the commonly used "two-times background" rule.
Yale Journal of Biology and Medicine, New Haven
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
CERTAIN TOXIC EFFECTS OF SULFANILAMIDE
Authors: M. C. P.
Journal: Annals of Internal Medicine (1937)

Editorial1 October 1937CERTAIN TOXIC EFFECTS OF SULFANILAMIDEM. C. P.M. C. P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-11-4-687 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptMany men in the past months have likened in their minds the present era in the treatment of infections to that period of excitement which immediately followed the first clinical use of Ehrlich's "606." Indeed many have felt that in the new drug, sulfanilamide, the medical profession had obtained a therapeutic agent of greater importance to humanity than even salvarsan itself.So chastened are many medical men as a result of repeated chemotherapeutic disappointments that the earlier announcements of the striking influence of this drug on certain coccal infections were met with a certain degree of cynicism. A larger number,...1 MENVILLEARCHINARD JGJJ: Skin eruptions in patients receiving sulfanilamide, Jr. Am. Med. Assoc., 1937, cix, 1008. CrossrefGoogle Scholar2 GOODMANLEVY MHCS: Eruption during administration of sulfanilamide, Jr. Am. Med. Assoc., 1937, cix, 1009. CrossrefGoogle Scholar3 FRANK LJ: Dermatitis from sulfanilamide, Jr. Am. Med. Assoc., 1937, cix, 1011. CrossrefGoogle Scholar4 SOUTHWORTH H: Acidosis associated with the administration of para-aminobenzene-sulfonamide (Prontylin), Proc. Soc. Exper. Biol. and Med., 1937, xxvi, 58-61. CrossrefGoogle Scholar5 HARVEYJANEWAY AMCA: Development of acute hemolytic anemia during administration of sulfanilamide, Jr. Am. Med. Assoc., 1937, cix, 12. CrossrefGoogle Scholar6 KOHN SE: Acute hemolytic anemia during treatment with sulfanilamide, Jr. Am. Med. Assoc., 1937, cix, 1005. CrossrefGoogle Scholar7 BUCY PC: Toxic optic neuritis resulting from sulfanilamide, Jr. Am. Med. Assoc. 1937, cix, 1007. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 October 1937Volume 11, Issue 4Page: 687-690KeywordsDrugsEhrlichiosis ePublished: 1 December 2008 Issue Published: 1 October 1937 PDF downloadLoading ...
The Proteins in Nasal Secretion
Authors: Roger D. Rossen
Journal: JAMA (1970)

Following influenza virus infection, virus-neutralizing antibody was detected earlier, rose to high titers sooner, and was demonstrable more frequently in nasal washings from men who had had relatively high concentrations of immunoglobulin A (IgA) in their nasal washings prior to the infection. Four men who had relatively low levels of nasal IgA before inoculation were the only ones who experienced typical febrile influenza. Virus-neutralizing antibody was detected relatively late and infrequently in the postinoculation nasal washings from these men. These findings suggest that the immunologic response to influenza virus at the mucous membrane surface may play a role in limiting infection, and thereby avert clinical illness.
Epidemiological research
Authors: Mona Okasha
Journal: BMJ (2001)

In the second article of our series on epidemiology Mona Okasha explains the different types of study involved Epidemiology may seem difficult to understand. It has concepts and words very different to those that you come across in the rest of your medical training. In this article I give an overview of what types of studies are available to us, with examples of when and when not to consider each type. I have not included an exhaustive list of advantages and disadvantages; these are available in most textbooks. The next article will concentrate on how to interpret study results.
The epidemiology of murder-suicide
Authors: P. M. Marzuk
Journal: JAMA (1992)

<h3>Objective.</h3> —To review the epidemiology, patterns, and major determinants of murder-suicide and to discuss the clinical and research strategies for identifying the individuals at greatest risk for this type of violence. <h3>Data Sources.</h3> —Data were obtained from English-language articles based on searches using MEDLINE (from 1966), PsychINFO (from 1967), and EMBASE (from 1974) programs. In addition, relevant articles, books, and monographs identified from the reference list of retrieved articles were reviewed. <h3>Study Selection.</h3> —Case-control studies, descriptive epidemiologic surveys, and case series were chosen for review. <h3>Data Extraction.</h3> —Because of the limited scope of the pertinent research literature, all data relevant to the incidence, demographics, circumstances, and precipitants of murder-suicide were summarized by the authors. <h3>Data Synthesis.</h3> —Murder-suicide occurs with an annual incidence of 0.2 to 0.3 per 100000 person-years and accounts for approximately 1000 to 1500 deaths yearly in the United States. The annual incidence of these events is relatively constant across industrialized nations and has not significantly changed over several decades. The principal perpetrators are young males with intense sexual jealousy, depressed mothers, or despairing elderly men with ailing spouses. The principal victims are female sexual partners or consanguineous relatives, usually young children. Clinical depression, specific motivations such as male sexual proprietariness or maternal salvation fantasies, and a history of previous suicide attempts are important in explaining underlying psychopathological mechanisms. <h3>Conclusions.</h3> —Murder-suicide occupies a distinct epidemiological domain that overlaps with suicide, domestic homicide, and mass murder. These events may be categorized into one of only several phenomenologic typologies that share similar demographics, motivations, and circumstances. Despite the disruption of families and communities caused by murder-suicide, there are no standardized operational definitions, validated taxonomic systems, or national surveillance networks for these events, all of which are needed to develop prevention strategies. (<i>JAMA</i>. 1992;267:3179-3183)
IMPROVEMENT IN FOOTBALL PATHOLOGY.
Journal: JAMA (1906)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE INNOCENT, THE AFFLICTED, AND "CANCER CURES"
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PRACTICAL NOTES.
Journal: JAMA (1998)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE SERUM DISEASE.
Journal: JAMA (1906)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diet and congenital defects.
Authors: D Gamble, K Taylor, M Kinsley, M Fitzgerald
Journal: BMJ (1973)

Serum Neutralizing Antibody Tests in Tissue Culture Coxsackie Sera with Titres of 1/4 or Greater Significance of X' test) Diabetics Controls BI 35/102 (34%)54/201 (27%) Not significant B2 47/102 (46%) 90/201 (45%) B3 56/102 (55%) 107/201 (53%) B4 77/102 (75%) 120/201 (59%) P < 0-01 B5 46/102 (45%) 731201 (36%) P < 0-05give a significant answer and, in view of the difficulty of obtaining a suitable control group, we doubt whether fewer than 100 patients would suffice.It may be of interest that in our second survey 102 acute-onset diabetics have so far been compared with 201 controls by testing for the presence of serum neutralizing anti- body to Coxsackie B virus at a dilution of 1/4 and a significantly greater proporion of diabetics have been found to have antibodies to Coxsackie B4 virus than controls.The provisional results are shown in table above.In conclusion we would like to stress that, despite our further positive findings, it is still premature to draw further con- clusions about their possible clinical significance.We are, however, particularly anxious that further work on the relationship between virus infection and the aetiology of diabetes should not be impeded.Both laboratory and epidemiological in- vestigation of this problem is proceeding rapidly in the United States and large-scale studies ouoht similarly to be carried out in Western Europe.-Weare, etc.,
Morbid Obesity
Authors: Antonio Boba
Journal: JAMA (1976)

<h3>To the Editor.—</h3> Two recent items referred to the issue of morbid obesity (234:1158; 1190, 1975). Of late, the morbid aspect of obesity seems to have preoccupied both writers and editors, to wit the number of published reports dealing with that issue. To the careful reader, the obvious wide range of criteria that are proposed, often only implied, is quite disturbing. Indeed, at times one believes that an obese patient becomes "morbidly obese" only and as soon as he offends the esthetic sensitivity of the observer. The obvious answer to this quandary is the adoption of a precise quantitative measurement of obesity, specifically, the "ponderal index" (Figure). The obvious advantage of this type of measurement is that patients are then referred to, and grouped by, their ponderal index rather than by their weight. Because there is good statistical evidence that as the ponderal index decreases, the corrected life expectancy also
The Alzheimer Sonnets
Authors: Ronald Pies
Journal: JAMA (2001)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal